Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

May 20, 2007

Mylan Laboratories Names Hal Korman President of Mylan Pharmaceuticals

May 12, 2007

Mylan Laboratories to Acquire Generics Business of Merck KGaA

May 03, 2007

Mylan Announces Tentative FDA Approval for Letrozole Tablets, USP

May 02, 2007

Mylan Schedules Fourth Quarter and Fiscal 2007 Financial Results Conference Call and Live Webcast

Apr 23, 2007

Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets

Apr 18, 2007

FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets

Apr 13, 2007

Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets

Apr 10, 2007

U.S. District Court Grants Extension for Consideration of Amlodipine Besylate Exclusivity

Apr 10, 2007

Mylan Increases Fiscal 2007 Adjusted Diluted EPS Guidance to $1.60 - $1.63 Excluding Any Contribution from the Recent Launch of Amlodipine Besylate

Mar 27, 2007

U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs

Pagination

First page
Previous page
…
Page 98
Page 99
Page 100
Page 101
Current page 102
Page 103
Page 104
Page 105
Page 106
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.